Skip to content

Although pioneering scientist Gerald Reaven thought that insulin resistance did not affect the kidney, new research suggests that the story is more complex.

Although pioneering scientist Gerald Reaven thought that insulin resistance did not affect the kidney, new research suggests that the story is more complex.

Published on

A diabetes program, developed with a Stanford scientist, helps cut costs of diabetes-related health care expenses by $815 per year per person.

A diabetes program, developed with a Stanford scientist, helps cut costs of diabetes-related health care expenses by $815 per year per person.

A design challenge called Disrupt Diabetes was created and spearheaded by two Stanford seniors — best friends and aspiring doctors who felt that innovations for people with diabetes should bubble up from patients’ daily experiences and priorities.

A design challenge called Disrupt Diabetes was created and spearheaded by two Stanford seniors — best friends and aspiring doctors who felt that innovations for people with diabetes should bubble up from patients’ daily experiences and priorities.

This video highlights Stanford Health Care's team-based approach to diabetes care. Patient Hazel shares her experience helping to design a treatment plan.

This video highlights Stanford Health Care's team-based approach to diabetes care. Patient Hazel shares her experience helping to design a treatment plan.

In this final installment of the "Breaking down diabetes" series, physician-researcher Randall Stafford weighs in on a debate about blood sugar levels that relates to drug prices.

In this final installment of the "Breaking down diabetes" series, physician-researcher Randall Stafford weighs in on a debate about blood sugar levels that relates to drug prices.

In this Breaking Down Diabetes installment, physician-research Randall Stafford clarifies the pros and cons of insulin use in Type 2 diabetes.

In this Breaking Down Diabetes installment, physician-research Randall Stafford clarifies the pros and cons of insulin use in Type 2 diabetes.